Laparoscopic Colon and Rectal Surgery
Philip H. Gordon, Santhat Nivatvongs, Lee E. Smith, Scott Thorn Barrows, Carla Gunn, Gregory Blew, David Ehlert, Craig Kiefer, Kim Martens in Neoplasms of the Colon, Rectum, and Anus, 2007
Cobb et al. (180) examined the results of HAL colon surgery for benign disease in 37 patients. Indications for operation were: polyp (thirteen), uncomplicated diverticular disease (eight), complicated diverticular disease (i.e. colovesical fistula, phlegmon, etc.) (seven), chronic constipation (four), rectal prolapse (two), ulcerative colitis (one), endometriosis (one), and fecal incontinence (one). Procedures performed were sigmoidectomy (fourteen), right colectomy (nine), lower anterior resection (seven), subtotal colectomy (five), cecectomy (one), and transverse colectomy (one). There were no deaths. One case was converted to celiotomy (unable to rule out malignancy). The median operative time was 122 minutes. Return of flatus was noted (median) at postoperative day 3 and the median length of stay after operation was 4 days. One patient developed a superficial wound infection and there was one pelvic abscess (drained percutaneously) and one patient developed urinary retention. There were no reoperations.
Frequency of putative enteric zoster diagnosed using saliva samples in patients with abdominal pain: a prospective study
Published in Infectious Diseases, 2021
Sang Hyun Ra, Ji-Soo Kwon, Ji Yeun Kim, Hye-Hee Cha, Hyun-Jung Lee, Jiwon Jung, Min Jae Kim, Yong Pil Chong, Sang-Oh Lee, Sang-Ho Choi, Yang Soo Kim, Won Young Kim, Sung-Han Kim
We found that in five (10%) of the 50 patients, VZV-DNA PCR using saliva samples showed positive results. In Patients 1 and 2, pancreatic head cancer was seen on APCT. Patient 3 had undergone left partial nephrectomy for renal cell carcinoma one week before the date of study enrolment. However, there were no remarkable findings on radiologic images. Patients 4 and 5 were diagnosed with small bowel obstruction after intra-abdominal surgery. Patient 4 had undergone an ileostomy take-down operation after undergoing laparoscopic lower anterior resection for rectal cancer two weeks before the date of study enrolment. Patient 5 had undergone an ileostomy take-down operation after undergoing robot-assisted total colectomy/ileorectal anastomosis for ascending colon cancer two weeks before the date of visiting the emergency room. Detailed clinical characteristics of these five patients are presented in Table 2. On the contrary, all 14 patients with COVID-19 showed negative salivary VZV-DNA PCR results.
Severe Treatment-Related Lymphopenia in Patients with Newly Diagnosed Rectal Cancer
Published in Cancer Investigation, 2018
Jian L. Campian, Xiaobu Ye, Guneet Sarai, Joseph Herman, Stuart A. Grossman
Fifty-seven patients met the required eligibility criteria from a list of 163 patients with newly diagnosed stage II–III rectal cancer between 2005 and 2009 at the Johns Hopkins Hospital Cancer Registry. Baseline demographic information on these patients is provided in Table 1. The median age of the patients was 54 years (range 15–85) and 47% of the patients were over the age of 55. Sixty-four percent were male, 78% were Caucasian, and 62% had an ECOG performance status of zero. Ninety-five percent had neoadjuvant chemoradiation and only 5% had surgery prior concurrent chemoradiation. Thirty-three percent were clinical stage II, 67% were stage III and stage IV. Ninety-one percent were T stage 3 and 4, 9% were T stage 2. Thirty-three percent were N stage 0, 67% were N stage 1 and 2. Capecitabine was administered concurrently with radiation in 75% of patients and infusional 5-FU was administered in 16% of patients. Sixty-four percent had lower anterior resection, 25% had abdominoperineal resection (APR) and 11% did not undergo surgery. Only 2% of patients had positive margin in patients who had undergone surgical resection while 38% of patients had positive lymph nodes found in surgery. Seventy-two percent had no evidence of disease after completion of treatment at the time of the chart review and the duration of follow up was up to 7 years (Table 1).
Clinical role of fluorescence imaging in colorectal surgery - an updated review
Published in Expert Review of Medical Devices, 2020
Amandeep Ghuman, Sandra Kavalukas, Stephen P. Sharp, Steven D. Wexner
The multicentre phase II trial by Ris et al. not only showed change in bowel transection site in 5.8% due to hypoperfusion, but also correlated the change in operative strategy which resulted in no leaks in the patients in whom the margins were changed [10]. These findings are consistent with a retrospective cohort study done at our center for low rectal cancer cases, where we also showed a change in surgical plan in 13.3% with ICG, none of whom suffered an AL [15]. Another recent study revealed an ICG-induced change in proximal resection margin in 18.5% of patients who underwent transanal total mesorectal excision which resulted in a 3.7% rate of anastomotic leak [16]. Ris et al also noted a change in operative strategy of forgoing a protective ileostomy in five patients who underwent a lower anterior resection based on the ICG perfusion of the anastomosis. None of these patients developed an AL.
Related Knowledge Centers
- Abdominoperineal Resection
- Colorectal Cancer
- Quality of Life
- Rectal Tenesmus
- Diverticulitis
- Quality of Life